- Home
- PPIH vs ELDN Comparison
PPIH vs ELDN Comparison
Compare PPIH & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPIH
- ELDN
- Stock Information
- Founded
- PPIH 1993
- ELDN 2004
- Country
- PPIH United States
- ELDN United States
- Employees
- PPIH N/A
- ELDN N/A
- Industry
- PPIH Pollution Control Equipment
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- PPIH Industrials
- ELDN Health Care
- Exchange
- PPIH Nasdaq
- ELDN Nasdaq
- Market Cap
- PPIH 217.1M
- ELDN 202.4M
- IPO Year
- PPIH N/A
- ELDN N/A
- Fundamental
- Price
- PPIH $30.51
- ELDN $2.71
- Analyst Decision
- PPIH
- ELDN Strong Buy
- Analyst Count
- PPIH 0
- ELDN 2
- Target Price
- PPIH N/A
- ELDN $12.50
- AVG Volume (30 Days)
- PPIH 125.8K
- ELDN 683.9K
- Earning Date
- PPIH 09-19-2025
- ELDN 08-14-2025
- Dividend Yield
- PPIH N/A
- ELDN N/A
- EPS Growth
- PPIH N/A
- ELDN N/A
- EPS
- PPIH 1.55
- ELDN 0.21
- Revenue
- PPIH $170,810,000.00
- ELDN N/A
- Revenue This Year
- PPIH N/A
- ELDN N/A
- Revenue Next Year
- PPIH N/A
- ELDN N/A
- P/E Ratio
- PPIH $19.65
- ELDN $12.78
- Revenue Growth
- PPIH 9.96
- ELDN N/A
- 52 Week Low
- PPIH $8.81
- ELDN $2.38
- 52 Week High
- PPIH $32.90
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- PPIH 60.11
- ELDN 46.99
- Support Level
- PPIH $28.26
- ELDN $2.54
- Resistance Level
- PPIH $32.44
- ELDN $2.66
- Average True Range (ATR)
- PPIH 2.04
- ELDN 0.12
- MACD
- PPIH 0.02
- ELDN 0.03
- Stochastic Oscillator
- PPIH 64.06
- ELDN 60.61
About PPIH Perma-Pipe International Holdings Inc.
Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in the reportable segment of Piping Systems. The company engineers, designs, manufactures, and sells specialty piping systems and leak detection systems. Specialty piping systems include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids, and petroleum products, and the coating and insulation of oil and gas gathering and transmission pipelines. It operates in the United States, Canada, the Middle East, Europe, India, and other countries.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.